Chiropractic Therapy Helps Fibromyalgia Pain

If you suffer with fibromyalgia, you are not alone, as Montero Chiropractic Clinic sees many patients with this particular syndrome in our Yuma chiropractic clinic. In fact, the Centers for Disease Control and Prevention (CDC) reports that roughly 2% of all adults in the US have fibromyalgia issues. Luckily, chiropractic therapy is one treatment option that can provide positive results.

Research Shows Chiropractic Therapy Lessens Fibromyalgia Discomfort

In a study published in mid-2015, 215 women and men with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression symptoms or anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal treatment program for three months and the second group receiving the same program with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic adjustments in addition to the multi-disciplinary therapy approach reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study participants who received multi-modal treatment without chiropractic therapy. Additionally, those positive results were long-lasting as the patients reported continued improvement one full year later.

Fibromyalgia discomfort can significantly reduce your quality of life, both psychologically and physically. If you're struggling with fibromyalgia, we might be able to help.

You don't have to suffer! To learn what Montero Chiropractic Clinic can do for your fibromyalgia issues, call our Yuma chiropractic office today.

Sources

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.